| Earnings Per Share Our earnings per common share (“EPS”) were: | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended | | For the Nine Months Ended | | September 26, 2026 | | September 27, 2025 | | September 26, 2026 | | September 27, 2025 | | (in millions, except per share data) | | Basic Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | 544 | | | $ | 615 | | | $ | (4,118) | | | $ | (6,497) | | | Weighted average shares of common stock outstanding | 1,186 | | | 1,184 | | | 1,186 | | | 1,188 | | | Net earnings/(loss) | $ | 0.46 | | | $ | 0.52 | | | $ | (3.47) | | | $ | (5.47) | | | Diluted Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | 544 | | | $ | 615 | | | $ | (4,118) | | | $ | (6,497) | | | Weighted average shares of common stock outstanding | 1,186 | | | 1,184 | | | 1,186 | | | 1,188 | | | Effect of dilutive equity awards | 6 | | | 2 | | | — | | | — | | | Weighted average shares of common stock outstanding, including dilutive effect | 1,192 | | | 1,186 | | | 1,186 | | | 1,188 | | | Net earnings/(loss) | $ | 0.46 | | | $ | 0.52 | | | $ | (3.47) | | | $ | (5.47) | |
We use the treasury stock method to calculate the dilutive effect of outstanding equity awards in the denominator for diluted EPS. Anti-dilutive shares were 6 million for the three months and 18 million for the nine months ended September 26, 2026 and 5 million for the three months and 13 million for the nine months ended September 27, 2025.
|